Funding news
Cortical Labs logo

Cortical Labs Secures $11 Million in Seed Funding to Pioneer Next-Gen Neuronal Computing Technology

Recently funded · $11.0M SeedTechnology/Biotechnology

Get the full Cortical Labs company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Cortical Labs, an innovative biological computing startup, has successfully raised an impressive $11 million in its latest funding round. As pioneers at the forefront of biocomputing, Cortical Labs is on a mission to revolutionize the computing landscape by integrating live neurons into chips, heralding a new era dubbed the post-silicon age. This significant investment will enable the company to accelerate its research and development efforts, further refining its groundbreaking technology that merges biological processes with traditional computing systems. By harnessing the remarkable power of live neurons, Cortical Labs aims to create more adaptive, efficient, and intelligent computing solutions that can outpace current silicon-based technologies. The funding will also support the expansion of their engineering team, facilitating enhanced product development and enabling the scaling of their revolutionary neuron-chip interface. With the world’s growing reliance on computing power, Cortical Labs is committed to delivering a more sustainable, capable, and responsive approach to technology that could redefine how we interact with machines. The interest and backing from investors highlight their confidence in Cortical Labs' vision of a future where biological computing not only enhances traditional systems but also opens doors to unprecedented possibilities in artificial intelligence and machine learning. As we embark on this exciting journey into the post-silicon age, Cortical Labs is poised to change the narrative of computing as we know it. Stay tuned to see how this transformative technology unfolds.

Other recently funded companies

View all

Other recent Seed rounds

Companies that recently closed a Seed round.

#CompanyAmount
1
Edify logo

Edify

United States

$3.0M
2
Riverlution logo

Riverlution

United Kingdom

$40.4K
3
Goldenrod Therapeutics logo

Goldenrod Therapeutics

United States

$6.5M
4
HAGA.BIO logo

HAGA.BIO

Sweden

$2.3M
5
Hexigone Inhibitors logo

Hexigone Inhibitors

United Kingdom

$1.2M